GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regent Pacific Group Ltd (FRA:RPG) » Definitions » Revenue per Share

Regent Pacific Group (FRA:RPG) Revenue per Share : €0.00 (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Regent Pacific Group Revenue per Share?

Regent Pacific Group's revenue per share for the six months ended in Dec. 2023 was €0.00. Regent Pacific Group's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00.

Warning Sign:

Regent Pacific Group Ltd revenue per share has been in decline over the past 3 years.

During the past 3 years, the average Revenue Per Share Growth Rate was -50.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Regent Pacific Group's Revenue per Share or its related term are showing as below:

FRA:RPG' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -77.3   Med: -18.1   Max: 98.4
Current: -50.9

During the past 13 years, Regent Pacific Group's highest 3-Year average Revenue Per Share Growth Rate was 98.40% per year. The lowest was -77.30% per year. And the median was -18.10% per year.

FRA:RPG's 3-Year Revenue Growth Rate is ranked worse than
97.39% of 921 companies
in the Drug Manufacturers industry
Industry Median: 6.1 vs FRA:RPG: -50.90

Regent Pacific Group Revenue per Share Historical Data

The historical data trend for Regent Pacific Group's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regent Pacific Group Revenue per Share Chart

Regent Pacific Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 -0.03 -

Regent Pacific Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.03 - -

Competitive Comparison of Regent Pacific Group's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regent Pacific Group's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's PS Ratio falls into.



Regent Pacific Group Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Regent Pacific Group's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=0.35/225.103
=0.00

Regent Pacific Group's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )=Revenue (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=0.275/228.443
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regent Pacific Group  (FRA:RPG) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Regent Pacific Group Revenue per Share Related Terms

Thank you for viewing the detailed overview of Regent Pacific Group's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Regent Pacific Group Business Description

Traded in Other Exchanges
Address
5 Queen's Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd Formerly Endurance RP Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan.